EP1572: A novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man

  • F. Broglio
  • , F. Boutignon
  • , A. Benso
  • , C. Gottero
  • , F. Prodam
  • , E. Arvat
  • , C. Ghè
  • , F. Catapano
  • , A. Torsello
  • , V. Locatelli
  • , G. Muccioli
  • , D. Boeglin
  • , V. Guerlavais
  • , J. A. Fehrentz
  • , J. Martinez
  • , Ezio Ghigo
  • , R. Deghenghi

Research output: Contribution to journalArticlepeer-review

Abstract

EP1572 (JMV1843 [Aib-DTrp-DgTrp-CHO]) is a new peptido-mimetic GH secretagogue (GHS) showing binding potency to the GHS-receptor in animal and human tissues similar to that of ghrelin and peptidyl GHS. EP1572 induces marked GH increase after sc administration in neonatal rats. Preliminary data in 2 normal young men show that: 1) acute iv EP1572 administration (1.0 μg/kg) induces strong and selective increase of GH levels; 2) single oral EP1572 administration strongly and reproducibly increases GH levels even after a dose as low as 0.06 mg/kg. Thus, EP1572 is a new peptido-mimetic GHS with potent and selective GH-releasing activity.

Original languageEnglish
Pages (from-to)RC26-RC28
JournalJournal of Endocrinological Investigation
Volume25
Issue number8
DOIs
Publication statusPublished - Sept 2002
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • GH
  • Ghrelin receptors
  • Humans
  • Oral administration
  • Synthetic GH secretagogues

Fingerprint

Dive into the research topics of 'EP1572: A novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man'. Together they form a unique fingerprint.

Cite this